Balance@Work: the (cost)-effectiveness of an occupational health guideline to improve physical activity and dietary behaviour among workers in order to prevent weight gai

Completed

• Conditions: Obesity prevention; Nutritional, Metabolic, Endocrine; Obesity

• Registration Number: ISRCTN73545254
• Lead Sponsor: Vrije University Medical Centre (VUMC) (Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-09-02
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

1. Workers who do not comply to Dutch physical activity and nutrition guidelines, and/or workers who are overweight
2. Aged 18 - 55 years, either sex

Exclusion Criteria

1. Unable to be physically active
2. Not sufficiently capable of using the Dutch language
3. Not having signed an informed consent form
4. Sick leave for the last 3 weeks

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Physical activity, measured with the Squash questionnaire at baseline, 6, 12, and 18 months<br>2. Dietary behaviour, measured with the Short Fruit and Vegetable questionnaire and the Fat list at baseline, 6, 12, and 18 months<br>3. Waist circumference, measured with the Seca 201 waist circumference measure at baseline, 6, 12, and 18 months<br>4. Body weight at baseline, 6, 12, and 18 months

Secondary Outcome Measures

Name	Time	Method
1. General health status (sedentary behaviour measured with the International Physical Activity Questionnaire [IPAQ], anthropometrics [body weight, body height, blood pressure and cholesterol] measured retrospectively) at baseline, 6, 12, and 18 months<br>2. Quality of life, measured with the EQ-5D questionnaire at baseline, 6, 12, and 18 months<br>3. Cardiovascular disease risk profile, calculated following SCORE at baseline, 6, 12, and 18 months<br>4. Sick leave, measured with the HPQ questionnaire at 3, 6, 9, 12, 15, and 18 months<br>5. Cost-effectiveness, measured with EQ-5D and HPQ data at 3, 6, 9, 12, 15, and 18 months